Pharmafile Logo
Pharmafocus logo
Advanced Search
lonza

Lonza in $5.5 billion deal to acquire Capsugel

December 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Capsugel, Lonza, acquistion

Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …

News
digital_pharma

NICE and FDA to collaborate in medtech access scheme

December 15, 2016
Medical Communications, Sales and Marketing FDA, NICE

The National Institute of Health and Care Excellence (NICE) and the US Food and Drugs Administration (FDA) have announced their …

News
justice_department

Former CEO and president of generics company charged with price fixing

December 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeffrey glazer, heritage pharmaceuticals, jason malek

Jeffrey Glazer, ex-CEO of Heritage Pharmaceuticals, and Jason Malek, the former president, have been charged with conspiracy to fix prices. …

News
shutterstock_92671375

Five major pharma firms break ABPI code of conduct, according to watchdog

December 15, 2016
Medical Communications, Sales and Marketing ABPI, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Grunenthal, Janssen

Eli Lilly, Boehgringer Ingelheim, AstraZeneca UK, Grunenthal and Janssen-Cilag have been “named and shamed” by the Prescription Medicines Code of …

News
dementia

Director and location of £250 million UK Dementia Research Institute revealed

December 14, 2016
Medical Communications, Research and Development Alzheimer’s Research UK, Medical Research Council, alzheimer's research uk, alzheimer's society

Bart de Strooper has been chosen as the new director of the UK Dementia Research Institute (UK DRI), and University …

News
ritalin-sr-20mg-1000x1000

35% of all imported medicine in Guyana is fake, investigation finds

December 14, 2016
Medical Communications, Research and Development, Sales and Marketing Guyana, counterfeit medicine

As much as 35% of medicine imported into Guyana is fake and unsafe for use, according to findings by Allan …

News
new_york

New York in $500 million de Blasio-backed biotech boost

December 14, 2016
Manufacturing and Production, Research and Development New York, biotech, funding

Mayor of New York, Bill de Blasio, has announced a $500 million initiative to drive the development of the biotech …

News
actelion

Sanofi eyes Actelion merger as J&J backs down

December 14, 2016
Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …

News
barack-obama-1174489_960_720

Obama seals $6.3 billion 21st Century Cures Act

December 14, 2016
Medical Communications, Research and Development Biden, Obama, US, congress

President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …

News

Lilly offers insulin at 40% discount

December 13, 2016
Research and Development, Sales and Marketing Blink Health, Eli Lilly

Eli Lilly has announced that it will offer its insulin medication, including Humalog, at a 40% discount for eligible patients …

News

Specialist medical education company, Wave, has made six new appointments to reflect the growth in their business over the last 3 months.

December 13, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Becky Robbins, a former Healthcare Analyst at GlobalData, and Lorna Bosdet, formerly Account Executive at Sciterion have joined as Senior …

News
Press release
ceo_david_hallal_image_sqaure_image

Alexion loses CEO & CFO as internal investigation continues

December 13, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion

Alexion Pharmaceuticals has revealed that its CEO David Hallal (pictured) and CFO Vikas Sinha have resigned effective immediately in connection …

Appointment
medicity

Medicity in £1.4 million expansion in boost for life sciences

December 13, 2016
Manufacturing and Production BioCity, Boots, medicity

Medicity has announced that it has managed to raise the funds to refurbish an additional 29,800 square feet of space, …

News
13bg_fire_at_biocon

Major fire ravages Biocon subsidiary complex in India

December 13, 2016
Manufacturing and Production Biocon, Syngene

A subsidiary of Indian biopharmaceutical firm Biocon was gutted by a major fire at Electronic City, Bangalore on 12 December, …

News
sun_pharma

Sun Pharma’s Halol plant’s leaky roof irks FDA

December 13, 2016
Manufacturing and Production FDA, Sun Pharma, inspection

The FDA’s two week inspection of Sun Pharmaceutical’s Halol plant produced a 14-page report, with some criticisms reserved for poorly …

News
alexion_sign

Alexion loses CEO & CFO as internal investigation continues

December 12, 2016
Business Services, Manufacturing and Production, Medical Communications

Alexion Pharmaceuticals has revealed that its CEO David Hallal and CFO Vikas Sinha have resigned effective immediately in connection with …

News
jevtana_0

Scottish Medicines Consortium approves Sanofi’s prostate cancer drug

December 12, 2016
Manufacturing and Production, Sales and Marketing Jevtana, Sanofi, prostate cancer

Sanofi’s speciality care global business unit Sanofi Genzyme has announced that the Scottish Medicines Consortium has accepted the company’s Jevtana …

News
emma-harvey0006_horizontal

Rare challenges: Meeting patient needs and delivering medical innovation in ultra-rare diseases

December 12, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, ultra rare disease, ultra-rare disease

Dr Emma Harvey, ‎senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the …

Feature

Personalised leukaemia vaccine shows promise in new trial

December 12, 2016
Sales and Marketing leukaemia

A personalised cancer vaccine has proven to have significant efficacy in the treatment of acute myeloid leukaemia (AML), researchers at …

News
basel_site

Phase 3 eye drug combo failure for Novartis

December 12, 2016
Research and Development, Sales and Marketing Novartis, ophthotech

Novartis’ has failed in its attempt to expand the applications of its anti-VEGF eye treatment Lucentis (ranibizumab) after the drug …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026